Approx 4 Years ago in Feb 2020, Vection had only just acquired Mindesk. The SP was round 0.030 (pretty much the same as today). M/Cap was lower then at $25M as SOI was less at 822M shares.
Within 6 months, the SP rose exponentially… 8 times over to 0.24.
Many were caught out when over the following 8 months the SP had crashed back down below 0.06.
Those that held through the downtrend were rewarded however as VR1 pumped again 5 bags in the following 6 months to new ATH at 0.29.
Time showed this turned out to be an over reaction by the market, partly due to the excitement of the acquisition of JMC, moreso the Metaverse hype & numerous positive company announcements that accompanied it (which many of us got caught up in at the time). It also resulted in an opportune time to do a CR which (although proved extremely well timed in hindsight), very much lost trust & deflated sentiment in the company at the time & since with us being back below where it all started & now level with it.
Even 3 years following, Vection still struggles to regain trust as a result of that CR. As I see it, all that remain here today are a few die hard believers, a hand full of other crew with an interest in the technology & its potential, then theres the 2 lots of haters… those dedicated to Tenx & those to BM.
This last 4 years has seen a tech boom, then bust & what appears recently to be a significant increase in interest in the VR/XR space especially this last few months in big part due to the new Apple headset release. Many comment, its too expensive, it will never take off but if sales figures are accurate to date, that is not the case re the Apple VisionPro. Many are finding the funds to purchase this high end technology & most reviews are that these type of products will certainly play a big part in our futures both at home & at the workplace.
Numerous other companies are coming out with their own headsets, some equally expensive such as Vection partner Varjo, others especially cheap such as the Meta Oculus range by comparison. Either way, the retail market is not, nor has ever been Vections target market…it is the Enterprise / commercial clients with mass users & likely multiple locations. It is Vections software that has the ability to connect people from all over the world together to engage / train/ visualise in lifelike detail places / products that may not even exist as yet. Its pretty amazing if you ask me.
In that same time while admittedly yes, Vections debt has grown (mostly as a result of its acquisitions)…if you read the fine print on the quarterly the numerous sources of funding are related to the acquired companies (not purely Vection directly). As the same time, revenue, staff, contacts, reputation & offerings have grown significantly. We are not just Mindesk anymore, theres numerous sources of income from JMC, Blank Canvas, Inversion, Xinntex & MYR under our blanket of companies.
The defence announcement this week surprised many. It’s the first announcement of note in near on 6 months. The honesty in its presentation was refreshing. It was clear, concise, & oozed confidence, without any hype. 3 Years ago this $4.9M deal with minimal income deal would’ve been pumped in the wording of the announcement by VR1. However our recently appointed new chair Damian is obviously having an influence & setting a new foundation and pathway forward by re-building trust. Lets hope per the announcement once embedded within the end client, a non European government (which seems to have gone unnoticed), then we will see our solutions become more necessary to them & profitable to us with repeat / contractual work in Government.
Something that particularly excites me was news of the newly established ‘National Commission for the Application of Enabling and Immersive Technologies in Medicine’ which is (admittedly a mouthful), but a very exciting development. This is made up of a team of whats described as professionals and experts lead by Vections CEO & MD, Gianmarco Biagi. The job of this team is to introduce advanced technologies into the healthcare sector with intent to improve health services (beginning with, but not restricted to the over 1000 both public & private hospitals in Italy). This improvement is expected to be achieved by integrating VR, AR, MR, AI, & Virtual Assistance into a holistic system. The description of this fits perfectly with previous ASX releases by Vection which have used this terminology.
Assumedly in time, this could well be significant to us. Expectation would be successful integration into one or a few hospitals, should be easy to replicate nationally & internationally. That being said, best not get ahead of ourselves.
Interesting times ahead eitherway with progess in the tech & the partners such as Accenture & Cisco who over the past couple of years have seen & continue to promote Vection to massive tier 1 clients. There are multiple other projects / opportunities that have been previously announced & either forgotten / presumed dead which are very much still in the works & could explain certain expenditures & surprise many.
Its those kind of thing that will bring new eyes here & reasoning for a continued rise in SP. If the previous quarterly cost blowouts are controlled or alternatively better explained / justified /offset by profitable work from here on, then what is a likely $30M predicted annual revenue at current $35M M/cap makes 0.031 a pretty cheap entry IMO. Time will tell
Its very likely to be a very interesting run up to EOF IMO. All the best holders.
VR1 Price at posting:
3.1¢ Sentiment: Buy Disclosure: Held
(20min delay)